Review
Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt–Jakob disease: an evidence-based approach
Michael B. Coulthart, Gerard H. Jansen and Neil R. Cashman
CMAJ June 10, 2014 186 (9) E333-E339; DOI: https://doi.org/10.1503/cmaj.130720
Michael B. Coulthart
Canadian Creutzfeldt–Jakob Disease Surveillance System (Coulthart, Jansen), Public Health Agency of Canada, Ottawa, Ont.; the Department of Pathology and Laboratory Medicine (Jansen), The Ottawa Hospital — Civic Campus, Ottawa, Ont.; Brain Research Centre (Cashman), University of British Columbia, Vancouver, BC
PhDGerard H. Jansen
Canadian Creutzfeldt–Jakob Disease Surveillance System (Coulthart, Jansen), Public Health Agency of Canada, Ottawa, Ont.; the Department of Pathology and Laboratory Medicine (Jansen), The Ottawa Hospital — Civic Campus, Ottawa, Ont.; Brain Research Centre (Cashman), University of British Columbia, Vancouver, BC
MDNeil R. Cashman
Canadian Creutzfeldt–Jakob Disease Surveillance System (Coulthart, Jansen), Public Health Agency of Canada, Ottawa, Ont.; the Department of Pathology and Laboratory Medicine (Jansen), The Ottawa Hospital — Civic Campus, Ottawa, Ont.; Brain Research Centre (Cashman), University of British Columbia, Vancouver, BC
MD
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt–Jakob disease: an evidence-based approach
Michael B. Coulthart, Gerard H. Jansen, Neil R. Cashman
CMAJ Jun 2014, 186 (9) E333-E339; DOI: 10.1503/cmaj.130720